Albert David [ALBERTDAVD] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Albert David Ltd. wins in 9 metrics, Gujarat Themis Biosyn Ltd. wins in 11 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Albert David Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.00 | 73.73 | Albert David Ltd. |
| Price-to-Book Ratio | 1.08 | 13.36 | Albert David Ltd. |
| Debt-to-Equity Ratio | 10.51 | 27.04 | Albert David Ltd. |
| PEG Ratio | -0.17 | -17.55 | Albert David Ltd. |
| EV/EBITDA | -38.84 | 52.76 | Gujarat Themis Biosyn Ltd. |
| Profit Margin (TTM) | 2.98% | 29.99% | Gujarat Themis Biosyn Ltd. |
| Operating Margin (TTM) | 9.34% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 9.34% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 4.38% | 19.64% | Gujarat Themis Biosyn Ltd. |
| Return on Assets (TTM) | 3.36% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $-432.92M | $-251.22M | Gujarat Themis Biosyn Ltd. |
| Dividend Yield | 1.86% | 0.17% | Albert David Ltd. |
| 1-Year Return | -15.89% | 15.75% | Gujarat Themis Biosyn Ltd. |
| Price-to-Sales Ratio (TTM) | 1.32 | 22.23 | Albert David Ltd. |
| Enterprise Value | $1.80B | $36.09B | Gujarat Themis Biosyn Ltd. |
| EV/Revenue Ratio | 0.56 | 22.65 | Albert David Ltd. |
| Gross Profit Margin (TTM) | 69.05% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $565 | $15 | Albert David Ltd. |
| Earnings per Share (Diluted) | $16.88 | $4.40 | Albert David Ltd. |
| Beta (Stock Volatility) | 0.12 | -0.17 | Gujarat Themis Biosyn Ltd. |
Albert David Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Albert David Ltd. | -0.59% | 4.33% | 0.07% | 7.01% | -4.08% | -2.45% |
| Gujarat Themis Biosyn Ltd. | -0.57% | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Albert David Ltd. | -15.89% | 17.53% | 49.44% | 126.75% | 126.75% | 126.75% |
| Gujarat Themis Biosyn Ltd. | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
Performance & Financial Health Analysis: Albert David Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | ALBERTDAVD | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.11B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 9,456 | 79,452 |
| 90 Day Avg. Volume | 8,688 | 106,446 |
| Last Close | ₹721.35 | ₹385.10 |
| 52 Week Range | ₹579.90 - ₹957.50 | ₹225.05 - ₹479.00 |
| % from 52W High | -24.66% | -19.60% |
| All-Time High | ₹1,753.95 (Sep 02, 2024) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -58.87% | -19.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.10% |
| Quarterly Earnings Growth | 0.08% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.30% |
| Operating Margin (TTM) | 0.09% | 0.40% |
| Return on Equity (TTM) | 0.04% | 0.20% |
| Debt to Equity (MRQ) | 10.51 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹690.75 | ₹24.29 |
| Cash per Share (MRQ) | ₹498.03 | ₹0.92 |
| Operating Cash Flow (TTM) | ₹-111,139,000 | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹172.01M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.86% | 0.17% |
| Last 12-Month Dividend | ₹16.50 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Albert David Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | ALBERTDAVD (Apr 24, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.00 | 73.73 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.17 | -17.55 |
| Price to Sales (TTM) | 1.32 | 22.23 |
| Price to Book (MRQ) | 1.08 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹4.11B | ₹35.41B |
| Enterprise Value | ₹1.80B | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.56 | 22.65 |
| Enterprise to EBITDA | -38.84 | 52.76 |
| Risk & Other Metrics | ||
| Beta | 0.12 | -0.17 |
| Book Value per Share (MRQ) | ₹690.75 | ₹24.29 |
Financial Statements Comparison: Albert David Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALBERTDAVD (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 3.43B | 1.51B |
| Cost of Goods Sold | 1.18B | 318.78M |
| COGS % of Revenue | 34.5% | 21.1% |
| Gross Profit | 2.25B | 1.19B |
| Gross Margin | 65.5% | 78.9% |
| Research & Development | 28.92M | 34.37M |
| Operating Income (EBIT) | -28.11M | 642.49M |
| Operating Margin | -0.8% | 42.6% |
| EBITDA | 133.11M | 713.04M |
| EBITDA Margin | 3.9% | 47.3% |
| Pre-Tax Income | 252.28M | 655.38M |
| Pre-Tax Income % of Revenue | 7.3% | 43.5% |
| Income Tax | 80.27M | 167.66M |
| Income Tax % of Revenue | 2.3% | 11.1% |
| Net Income (Profit) | 172.01M | 487.72M |
| Profit Margin | 5.0% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | ALBERTDAVD (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 4.17M | 116.94M |
| Total Current Assets | 3.54B | 519.73M |
| Total Current Assets % of Revenue | 103.1% | 34.5% |
| Total Current Liabilities | 1.04B | 205.60M |
| Total Current Liabilities % of Revenue | 30.4% | 13.6% |
| Long-Term Debt | 13.31M | 296.36M |
| Long-Term Debt % of Revenue | 0.4% | 19.7% |
| Total Shareholders Equity | 3.92B | 2.48B |
| Retained Earnings | 2.49B | 2.37B |
| Retained Earnings % of Revenue | 72.6% | 157.4% |
| Property, Plant & Equipment | 100.54M | 411.30M |
Cash Flow Statement Comparison
| Metric | ALBERTDAVD (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | -111.14M | 970.68M |
| Operating Cash Flow % of Revenue | -3.2% | 64.4% |
| Capital Expenditures | -145.72M | -1.16B |
| Free Cash Flow | -432.92M | -251.22M |
| FCF Margin | -12.6% | -16.7% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALBERTDAVD | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 5.71M | 108.97M |
| Float Shares | 2.05M | 29.52M |
| % Held by Insiders | 64.05% | 71.98% |
| % Held by Institutions | 1.61% | 1.18% |
| % Held by Public | 34.34% | 26.84% |
Dividend Analysis & Yield Comparison: Albert David Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | ALBERTDAVD | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | ₹16.50 | ₹0.67 |
| Last 12-Month Dividend Yield | 1.86% | 0.17% |
| 3-Year Avg Annual Dividend | ₹17.50 | ₹0.22 |
| 3-Year Avg Dividend Yield | 1.16% | 0.17% |
| 3-Year Total Dividends | ₹52.50 | ₹0.67 |
| Ex-Dividend Date | Jul 25, 2025 | Sep 04, 2025 |